Tranexamic Acid in Treatment of Facial Erythema

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

August 1, 2022

Study Completion Date

August 30, 2022

Conditions
Patient With Facial Erythema
Interventions
DRUG

Tranexamic Acid 500 MG

Each patient received treatment on both sides of the face, one side treated by micro needling with 10% topical tranexamic acid, and othert side treated by 10% topical tranexamic acid alone every 2 weeks for 3 sessions

Trial Locations (1)

Unknown

Azhar University, Asyut

All Listed Sponsors
lead

Al-Azhar University

OTHER

NCT05897918 - Tranexamic Acid in Treatment of Facial Erythema | Biotech Hunter | Biotech Hunter